| Literature DB >> 27741314 |
Xi Fu1, Torsten Lindgren1, Gunilla Wieslander1, Christer Janson2, Dan Norbäck1.
Abstract
The aim was to study associations between work and home environment and prevalence and incidence of respiratory health and a history of atopy in a 3-y cohort of commercial pilots. A questionnaire was mailed in 1997 to all pilots in a Scandinavian airline company (N = 622); 577 (93%) participated. The same questionnaire was sent to the participants 3 years later, 436 participated (76%). There were questions on asthma, respiratory symptoms and infections, allergies, the cabin environment, psychosocial environment and the home environment. Associations were analyzed by multiple logistic regression, calculating odds ratios (OR) with 95% confidence intervals (95%CI). The incidence of doctors' diagnosed asthma and atopy were 2.4 and 16.6 per 1000 person years, respectively. Pilots changing type of flight during follow-up got more airway infections (OR = 11.27; 95% CI 2.39-53.14). Those reporting decreased work control (OR = 1.85; 95% CI 1.03-3.31 for 1 unit change) and those with environmental tobacco smoke (ETS) at home (OR = 3.73; 95% CI 1.09-12.83) had a higher incidence of atopy during follow up. Dampness or mould at home was associated with a higher prevalence of asthma symptoms (OR = 3.55; 95% CI 1.43-8.82) and airway infections (OR = 3.12 95% CI 1.27-7.68). Window pane condensation in winter at home, reported at baseline, was associated with increased incidence of asthma symptoms (OR = 4.14; 95% CI 1.32-12.97) and pilots living in newer buildings at baseline had a higher incidence of airway infections (OR = 5.23; 95% CI 1.43-19.10). In conclusion, lack of work control and ETS at home can be a risk factors for development of allergic symptoms in pilots. Window pane condensation at home can be a risk factor for incidence of asthma symptoms. Dampness and mould at home can be a risk factor for prevalence of asthma symptoms and airway infections and living in newer buildings can be a risk factor for incidence of airway infections.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27741314 PMCID: PMC5065138 DOI: 10.1371/journal.pone.0164954
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Flow chart of the study population.
Prevalence of demographic data, allergies and respiratory illness among nonparticipants at baseline, participants at baseline and participants at follow-up.
| Respiratory health variable | Nonparticipants at baseline (N = 141) (%) | Participants at baseline (N = 436) (%) | P-value | Participants at follow-up (N = 436) (%) | P-value |
|---|---|---|---|---|---|
| Female gender | 4.3 | 5.3 | 0.63 | 5.3 | 1.00 |
| Current smoker | 9.9 | 12.1 | 0.45 | 8.4 | 0.33 |
| Ever had asthma | 0.7 | 2.6 | 0.19 | 2.3 | 1.00 |
| Doctors’ diagnosed asthma | 0.7 | 1.4 | 0.53 | 2.5 | 0.06 |
| Pollen allergy | 12.9 | 16.9 | 0.29 | 19.4 | 0.06 |
| Furry pet allergy | 7.9 | 10.3 | 0.41 | 10.8 | 0.75 |
| Wheeze or whistling in the chest last 12 months | 14.3 | 7.6 | 5.7 | 0.27 | |
| Current bronchitis | 13.0 | 8.1 | 0.23 | 7.1 | 0.76 |
| Nonspecific hyperreactivity | 30.7 | 19.8 | 21.7 | 0.34 | |
| Airway infections | 13.5 | 10.7 | 0.35 | 9.7 | 0.62 |
a. Comparing prevalence among nonparticipants and participants at baseline, calculated by Chi square analysis for 2*2 tables.
b. Comparing prevalence among participants at baseline and at follow-up, calculated by McMemar test.
Prevalence of work environment factors among nonparticipants at baseline, participants at baseline and participants at follow-up.
| Work factor | Nonparticipants at baseline (N = 141) (%) | Participants at baseline (N = 436) (%) | P-value | Participants at follow-up (N = 436) | P-value |
|---|---|---|---|---|---|
| Often | 73.8 | 83.1 | 87.4 | 0.008 | |
| Sometimes | 19.9 | 13.9 | 11.9 | ||
| Seldom | 5.0 | 2.8 | 0.7 | ||
| Never | 1.4 | 0.2 | 0 | ||
| Never | 8.5 | 5.3 | 0.37 | 5.1 | 0.56 |
| Seldom | 46.8 | 53.8 | 52.9 | ||
| Sometimes | 41.8 | 38.3 | 38.8 | ||
| Often | 2.8 | 2.5 | 3.2 | ||
| Often | 13.4 | 8.6 | 0.12 | 11.1 | <0.001 |
| Sometimes | 24.8 | 31.1 | 38.0 | ||
| Seldom | 43.3 | 46.6 | 41.7 | ||
| Never | 18.4 | 13.7 | 9.3 | ||
| Often | 44.0 | 50.5 | 0.39 | 52.5 | 0.02 |
| Sometimes | 35.8 | 32.6 | 35.8 | ||
| Seldom | 11.4 | 11.9 | 8.4 | ||
| Never | 8.2 | 5.0 | 3.3 | ||
| Short haul flights without ETS | 73.0 | 63.1 | NA | NA | |
| Short haul flight with ETS | 9.2 | 17.9 | NA | ||
| Long haul flight with ETS | 17.7 | 19.0 | NA |
a. Comparing prevalence among nonparticipants and participants at baseline, calculated by Chi square analysis for 2*4 tables or 2–2 tables (long haul flight).
b. Comparing prevalence among participants at baseline and at follow-up, calculated by Wilcoxon signed rank test.
c. The recall time for the type of flights was last 7 days.
Prevalence of current home factors among nonparticipant at baseline, participants at baseline and participants at follow-up.
| Home factor | Nonparticipants at baseline (N = 141) (%) | Participants at baseline (N = 436) (%) | P-value | Participants at follow-up (N = 436) | P-value |
|---|---|---|---|---|---|
| Before 1960 | 29.5 | 31.3 | 0.82 | 34.3 | 0.52 |
| 1961–1975 | 27.3 | 23.8 | 20.9 | ||
| After 1975 | 43.2 | 44.9 | 44.8 | ||
| 19.9 | 21.9 | 0.68 | 15.8 | ||
| 29.1 | 21.3 | 26.5 | |||
| 9.3 | 8.3 | 0.95 | 4.6 | ||
| 23.4 | 26.3 | 0.49 | 26.7 | 1.00 | |
| 5.7 | 7.6 | 0.44 | 6.0 | 0.39 | |
| 11.4 | 13.7 | 0.49 | 11.8 | 0.21 |
aComparing prevalence among nonparticipants and participants at baseline, calculated by Chi square analysis for 2*2 tables or 2*3 tables (construction year)
bComparing prevalence among participants at baseline and at follow-up, calculated by McMemar test or Wilcoxon signed rank test.
Number of new cases and symptom incidence during follow up.
| Outcome | N | N | Number of new cases | 3-year incidence (%) |
|---|---|---|---|---|
a. Asthma symptoms: wheezing in chest at any time, attack of breathlessness at rest, attacks of breathlessness after exercise, woken up by attacks of breathlessness, and asthma attack last 12 month.
b. Pollen or furry pet allergy.
c. Number of participants without particular symptom at baseline.
d. Number of participants without particular symptom at baseline, and the subjects who had ever had asthma at baseline (N = 11) were excluded.
e. Data in parenthesis refers to number of new cases and incidence of asthma symptoms when subjects who had ever had asthma at baseline (N = 11) were excluded.
Associations between symptom prevalence and baseline exposure (N = 436) .
| Selected variables | adj OR(CI 95%) | p-value |
|---|---|---|
a. The variables were selected by Wald stepwise logistic regression, and the cut-off p-value for the inclusion of variables in the model was 0.1. The stepwise logistic regression model for prevalence of asthma symptoms, bronchitis, nonspecific hyperreactivity and airway infections included following candidate variables: age, gender, atopy, smoking habits; work-related factors: flight type, stimulation at work, work demand, work control, support at work; home environment factors: construction year, multifamily/house, furry pet keeping, ETS at home, indoor painting last 12 months, dampness/mould last 12 months, window condensation in winter. The stepwise logistic regression model for atopy included all the factors included in the other models except atopy.
b. The associations between health variables displayed in this table were calculated by a mutual logistic regression model separately, including the selected independent variables for each health variable, adjusted by age, gender, and smoking habit.
c. For the psychosocial variables, OR was calculated for one step on the scale (0–1).
d. For the variable of age, OR was calculated for each escalation of 10 years.
Associations between symptom 3-year incidence and baseline exposure and change of exposure .
| Selected variables | adj OR(CI 95%) | p-value |
|---|---|---|
a. The variables were selected by Wald stepwise logistic regression, and the cut-off p-value for the inclusion of variables in the model was 0.1. The stepwise logistic regression model for incidence of asthma symptoms, bronchitis, nonspecific hyper-reactivity and airway infections included variables stating baseline exposure and the change during follow-up of following factors: age, gender, atopy, smoking habits; work-related factors: flight type, stimulation at work, work demand, work control, support at work; home environment factors: construction year, multifamily/house, furry pet keeping, ETS at home, indoor painting last 12 months, dampness/mould last 12 months, window condensation in winter. The stepwise logistic regression model for atopy included all the factors included in the other models except atopy.
b. The associations between symptoms displayed in this table were calculated by a mutual logistic regression model separately, including the selected independent variables for each health variable, adjusted by age, gender, and smoking habit.
c. For the psychosocial variables, OR was calculated for one step on the scale (0–1).
d. For the variable of age, OR was calculated for each escalation of 10 years.